We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $610M
1-Year Est. Return 40.86%
This Fund
S&P 500
This Quarter Est. Return
+50.27%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$249M
AUM Growth
-$66.5M
Cap. Flow
-$114M
Cap. Flow %
-45.59%
Top 10 Hldgs %
68.57%
Holding
50
New
9
Increased
9
Reduced
16
Closed
16

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.33M
2
PRTA icon
Prothena Corp
PRTA
+$3.98M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$3.57M
4
PRVA icon
Privia Health
PRVA
+$2.96M
5
KIDS icon
OrthoPediatrics
KIDS
+$2.75M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$31.6M
2
PCRX icon
Pacira BioSciences
PCRX
+$27.9M
3
KURA icon
Kura Oncology
KURA
+$9.66M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$8.5M
5
INSP icon
Inspire Medical Systems
INSP
+$7.94M

Sector Composition

Rank Sector Weight
1 Healthcare 95.92%
2 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDRX
26
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.89M 0.76%
+180,000
New +$2.21M
ORIC icon
27
CALL
Oric Pharmaceuticals
ORIC
$1.25B
$1.84M 0.74%
+200,000
New +$1.45M
BBSI icon
28
Barrett Business Services
BBSI
$976M
$1.51M 0.6%
52,000
-33,548
-39% -$865K
ERAS icon
29
Erasca
ERAS
$6.63B
$1.28M 0.51%
599,458
+334,748
+126% +$706K
SYRE icon
30
Spyre Therapeutics
SYRE
$8.87B
$1.18M 0.48%
+55,000
New +$758K
SWAV
31
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$953K 0.38%
+5,000
New +$945K
DSGN icon
32
Design Therapeutics
DSGN
$736M
$742K 0.3%
280,000
-923,745
-77% -$2.12M
BMEA icon
33
Biomea Fusion
BMEA
$90.4M
$624K 0.25%
42,991
-51,826
-55% -$630K
ALKS icon
34
Alkermes
ALKS
$8.82B
$416K 0.17%
15,000
-50,000
-77% -$1.3M
AGL icon
35
Agilon Health
AGL
$1.64B
– –
-3,163
Closed -$1.4M
CHE icon
36
Chemed
CHE
$6.78B
– –
-2,500
Closed -$1.3M
CMPX icon
37
Compass Therapeutics
CMPX
$373M
– –
-935,157
Closed -$1.84M
CNC icon
38
Centene
CNC
$31.3B
– –
-80,000
Closed -$5.51M
ELUT icon
39
Elutia
ELUT
$41.1M
– –
-25,594
Closed -$36.6K
EOLS icon
40
Evolus
EOLS
$394M
– –
-126,982
Closed -$1.16M
HUM icon
41
Humana
HUM
$46.7B
– –
-65,000
Closed -$31.6M
INSP icon
42
Inspire Medical Systems
INSP
$1.42B
– –
-40,000
Closed -$7.94M
IRTC icon
43
iRhythm Holdings
IRTC
$3.59B
– –
-35,000
Closed -$3.3M
MASI
44
DELISTED
Masimo
MASI
– –
-40,000
Closed -$3.51M
PEN icon
45
Penumbra
PEN
$12.5B
– –
-13,500
Closed -$3.27M
TDOC icon
46
Teladoc Health
TDOC
$1.58B
– –
-250,000
Closed -$4.65M
ZYME icon
47
Zymeworks
ZYME
$1.68B
– –
-106,405
Closed -$675K
NARI
48
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-130,000
Closed -$8.5M
NSTG
49
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-3,446,274
Closed -$5.93M
LBPH
50
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
– –
-321,154
Closed -$1.79M
1
2

Similar funds

PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return
BFC
Blue Fin Capital Warren, Rhode Island $610M AUM 26.46% 1-Year Est. Return
DCM
DGS Capital Management Jersey City, New Jersey $609M AUM 44.78% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return
CBB
Citizens Business Bank Ontario, California $610M AUM 27.86% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
CIP
Convergence Investment Partners Palm Beach Gardens, Florida $611M AUM 61.48% 1-Year Est. Return

Prosight Management's Q4 2023 Portfolio in Review

As of Q4 2023, Prosight Management held 50 positions worth $249M, down 21% from $316M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Prosight Management withdrew a net $114M in Q4 2023, closing 16 positions and reducing 16 holdings. Its most notable exit was Humana, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 99% a quarter earlier, followed by Industrials.

Against the trend, Prosight Management opened a new position in Privia Health worth $3.04M.

  • Prosight Management's largest Q4 2023 buy was Privia Health: 132,158 shares worth $3.04M.
  • Prosight Management added most to Medtronic in Q4 2023, an estimated $5.33M increase.
  • Prosight Management's biggest Q4 2023 reduction was Pacira BioSciences, cutting an estimated $27.9M.
  • Prosight Management fully exited Humana in Q4 2023, selling an estimated $31.6M.
  • Prosight Management's ten largest holdings make up 69% of its $249M portfolio in Q4 2023.
  • Prosight Management opened 9 new positions and closed 16 in Q4 2023.
  • Prosight Management's portfolio value fell 21% quarter-over-quarter to $249M.

Based on Prosight Management's 13F filing for Q4 2023, filed 14 Feb 2024.